MoneyWorks4Me

Lactose (India) informs about outcome of board meeting

19 Mar 2022 Evaluate

In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lactose (India) has informed the Stock Exchange that the Board of Directors of the Company at their meeting held on Saturday, 19th March, 2022 has, considered the Appointment of Dhaval Jayant Soni as an Independent Director of the company with effect from 19th March, 2022 for a period of 5 years. The meeting commenced at 02.00 pm and concluded at 03:00 pm.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..